1
|
Mordhorst A, Yang GK, Reitsma N, Chen JC, Zhang BY, Suri S, Gagnon J. Evaluation of hydrophilic polymer embolization from endovascular sheath devices in an in vitro perfusion system. JVS Vasc Sci 2023; 4:100127. [PMID: 37928834 PMCID: PMC10624583 DOI: 10.1016/j.jvssci.2023.100127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Accepted: 08/28/2023] [Indexed: 11/07/2023] Open
Abstract
Objective Case reports, tissue pathology, and autopsies have suggested that the hydrophilic polymer coating designed to improve endovascular deliverability and minimize vessel trauma can embolize and be associated with adverse outcomes such as ischemia, infarction, and death. This study sought to determine whether hydrophilic polymers shed off commercially available sheaths in a controlled in vitro environment, with the hypothesis that significant differences between coated and uncoated (control) sheaths would be found. Methods Six sheaths from each manufacturer, including Zenith Alpha abdominal endovascular stent grafts (Cook Medical), DrySeal sheaths (W.L. Gore & Associates), and Sentrant Introducer sheaths (Medtronic), were tested in an in vitro environment. Noncoated Check-Flo performer introducer sheaths (Cook Medical) were used as controls. Each test circuit ran for 150 minutes at an output of 3 L/min, the circuit was then drained and the fluid collected. Quantitative analysis included weighing the dried filter paper and using particle size light scattering to quantify the particle size and count. Attenuated total reflectance spectroscopy was also used. Results Each of the three coated sheaths had significantly greater shedding compared with the control sheaths. The Cook Zenith alpha sheath had significantly more residue weight (2.87 ± 0.52 mg/L) than the Gore DrySeal (1.07 ± 0.06 mg/L) and Medtronic Sentrant introducer (0.98 ± 0.14 mg/L) sheaths. The average particle size was not significantly different between the coated and uncoated (control) sheaths. Attenuated total reflectance spectroscopy identified sheath particulate in the Cook Zenith Alpha and Medtronic Sentrant samples. Conclusions Polymer embolization was present and significantly greater in all three commercially available hydrophilic sheaths compared with the control group. Further investigation is needed into the clinical significance of these findings.
Collapse
Affiliation(s)
- Alexa Mordhorst
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Gary K. Yang
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Nicholas Reitsma
- Department of Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Jerry C. Chen
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Bei Yuan Zhang
- Department of Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Sahib Suri
- Department of Chemistry, University of British Columbia, Vancouver, BC, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
2
|
Mordhorst A, Yan TD, Hoskins N, Gagnon J, Kazemi K. Percutaneous proximal axillary artery versus femoral artery access for endovascular interventions. Eur J Vasc Endovasc Surg 2022. [DOI: 10.1016/j.ejvs.2022.07.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
3
|
McClure GR, Ratnayake G, Chan A, Gagnon J. Percutaneous closure of a post-surgical ascending aortic pseudoaneurysm with an amplatzer septal occluder device and steerable guiding sheath. Catheter Cardiovasc Interv 2021; 98:E985-E989. [PMID: 34586756 DOI: 10.1002/ccd.29951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2021] [Revised: 08/30/2021] [Accepted: 09/01/2021] [Indexed: 11/07/2022]
Abstract
Thoracic pseudoaneurysm in the ascending aorta is an uncommon condition associated with significant risk of morbidity and mortality. Treatment is recommended in all cases regardless of symptoms as the mortality rate if left untreated has been documented to be as high as 61%. The current standard of care for managing these lesions is open surgical repair. However, this is associated with significant morbidity. In-hospital mortality reported for patients undergoing surgical repair of an ascending aortic pseudoaneurysm ranges from 6.7% to 41%. When anatomically suitable, a less invasive approach using amplatzer vascular plug or septal occluder is an attractive approach. We present a case report of repair of a post-surgical ascending aortic false aneurysm using an amplatzer septal occluder with an Oscor ™ steerable guiding sheath; a novel approach to increase platform stability when engaging an aneurysm neck. Endovascular occluder deployment for closure of aortic false aneurysms remains a relatively novel technique. It is limited by the requirement to develop a stable endovascular platform to deliver the device and avoid system prolapse, particularly when accessing challenging lesions on the inner aortic curvature. We present the first case to utilize a steerable guiding sheath system to improve system stability and facilitate successful device delivery. Given the significant morbidity associated with open repair of these lesions we hope this will further expand the range of lesions viewed as appropriate for endovascular repair.
Collapse
Affiliation(s)
- Graham R McClure
- Department of Surgery, McMaster University, Hamilton, Ontario, Canada.,Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada
| | - Geemitha Ratnayake
- Michael G Degroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Albert Chan
- Department of Medicine, University of British Columbia, New Westminster, British Columbia, Canada.,Division of Interventional Cardiology, Royal Columbian Hospital, New Westminster, British Columbia, Canada
| | - Joel Gagnon
- Department of Surgery, University of British Columbia, New Westminster, British Columbia, Canada.,Division of Vascular Surgery, Royal Columbian Hospital, New Westminster, British Columbia, Canada
| |
Collapse
|
4
|
Mordhorst A, Yan T, Gagnon J, Kazemi K. Percutaneous Proximal Axillary Artery Versus Femoral Artery Access for Aortic and Peripheral Endovascular Interventions. J Vasc Surg 2021. [DOI: 10.1016/j.jvs.2021.08.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
5
|
Peixoto EM, Oliveira KDS, Campos CR, Gagnon J, Zanini DS, Nakano TDC, Bueno JMH. DASS-21: assessment of psychological distress through the Bifactor Model and item analysis. Psico-USF 2021. [DOI: 10.1590/1413-82712021260413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Abstract The term distress has been used to refer to a continuous variable operationalized through symptoms of depression, anxiety, and stress. In this study, psychological distress is measured using the Depression, Anxiety, and Stress Scale (DASS-21). Confirmatory Factor Analysis compared the fit of different measurement models for the DASS-21, with the parameters of the items verified through the Andrich rating scale model. A non-clinical sample of 530 participants (mean age=24.35±6.55 years; 71.89% women) responded to the instrument. According to the theoretical hypothesis, the results indicated a better fit for the bifactor model, composed of three specific factors (depression, anxiety, and stress) and a general factor (general psychological distress). The assessment of the item properties allowed for a better understanding of the organization of the continuum represented by the construct psychological distress. It is possible to conclude that the Brazilian version of the DASS-21 is an adequate measure for psychological distress.
Collapse
Affiliation(s)
| | | | | | - Joel Gagnon
- Universté du Quebéc à Trois Rivieres, Canadá
| | | | | | | |
Collapse
|
6
|
Mordhorst A, Yan T, Gagnon J, Kazemi K. Percutaneous Proximal Axillary Artery Access Versus Femoral Artery Access for Aortic and Peripheral Endovascular Interventions. J Vasc Surg 2021. [DOI: 10.1016/j.jvs.2021.07.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
7
|
Abstract
Objective The use of cyanoacrylate products (CA) in incompetent perforator vein (IPV) treatment has not been thoroughly examined. The primary objective of this study is to describe the technique of ultra sound guided direct injection of IPV with CA, and secondarily to determine early closure rates and safety of this technique. Methods A retrospective analysis of patients undergoing IPV injection at two centres between 2015-2018 was conducted. Demographics, CEAP classification and IPV location were collected. Outcomes were assessed at two follow-up appointments. Results A total of 83 perforator vein injections were completed. CEAP classifications include C2 – C6 classes. Location of perforators were posteromedial (6%), femoral canal (9%), paratibial (14%), and posterior-tibial (71%). IPV closure rates were 96.3% at initial follow-up (16 ± 2 days). Closure rates decreased to 86.5% at second follow-up (72 ± 9 days). There were no deep vein thromboses during follow-up. One patient developed septic thrombophlebitis that was successfully managed with antibiotics. Conclusion Ultrasound-guided CA glue injection is a simple and low risk procedure that effectively closes incompetent perforator veins.
Collapse
Affiliation(s)
- Alexa Mordhorst
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Gary K Yang
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Jerry C Chen
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Shung Lee
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
8
|
Choi SHJ, Yang GK, Baxter K, Gagnon J. Evaluation of Aortic Zone 2 Proximal Landing Accuracy During Thoracic Endovascular Aortic Repair Following Carotid-Subclavian Revascularization. Vasc Endovascular Surg 2021; 55:355-360. [PMID: 33535904 DOI: 10.1177/1538574421989851] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Adequate seal for thoracic endovascular aortic repair (TEVAR) commonly requires landing in zone 2, but can prove to be challenging due to the tortuous and angulated anatomy of the region. OBJECTIVES Our objective was to determine the proximal landing accuracy of zone 2-targeted TEVARs following carotid-subclavian revascularization (CSR) and its impact on clinical outcomes. METHODS Retrospective review of patients that underwent CSR for zone 2 endograft delivery at a tertiary institute between January 2008 and March 2018 was conducted. Technical outcomes were assessed by examining the incidence of intraoperative corrective maneuvers, 1a endoleaks and reinterventions. Distance to target and incidence of LSA stump filling were examined as radiographic markers of landing accuracy. RESULTS Zone 2-targeted TEVAR with CSR was performed in 53 patients for treatment of dissections (49%), aneurysms (30%) or trauma (21%). Nine (17%) cases required intraoperative corrective procedures: 5 (9%) proximal cuffs due to type 1a endoleak and 4 (8%) left common carotid artery (LCCA) stenting due to inadvertent coverage. Cases performed using higher resolution hybrid fluoroscopy machine compared to mobile C-arm were associated with increased proximal cuff use (OR 8.8; 95% CI 1.2-62.4). Average distance between the proximal edge of the covered graft to LCCA was 8 ± 1 mm and larger distances were not associated with higher rates of 1a endoleak. Twenty-eight (53%) cases of antegrade LSA stump filling were noted on follow-up imaging, but were not associated with higher rates of reinterventions (OR 0.8, 95% CI [0.2-4.6]). Three (6%) patients had a stroke within 30 days and 4 (8%) patients expired within 1 month. Intraoperative corrective maneuvers, post-operative 1a endoleak and reinterventions were not associated with higher rates of stroke or mortality. CONCLUSION Using current endografts and imaging modalities, zone 2-targeted TEVARs have suboptimal technical accuracy.
Collapse
Affiliation(s)
- Sally H J Choi
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Gary K Yang
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Keith Baxter
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
9
|
Vasudevan T, Robinson DA, Hill AA, Ouriel K, Holden A, Gagnon J, Machan L, Nammuni I, Thomas SD, Varcoe RL. Safety and feasibility report on nonimplantable endovenous valve formation for the treatment of deep vein reflux. J Vasc Surg Venous Lymphat Disord 2021; 9:1200-1208. [PMID: 33359385 DOI: 10.1016/j.jvsv.2020.12.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Accepted: 12/03/2020] [Indexed: 10/22/2022]
Abstract
OBJECTIVE Definitive treatment techniques for symptomatic deep venous reflux have been relegated to complex and invasive open surgery which is rarely performed today. The BlueLeaf System provides an endovenous method for the formation of deep venous valves without an implant, avoiding the complications associated with permanent foreign materials. The system has the adaptability to form valves within the femoral and popliteal veins at multiple levels in a single procedure. The aim was to determine the midterm safety and efficacy of this novel device in an early feasibility study. METHODS Feasibility of endovenous deep venous valve formation was assessed in patients with chronic venous insufficiency (Clinical, Etiologic, Anatomic, Pathophysiologic [CEAP] 4-6). Follow-up was completed through 1 year, assessing vein patency and reflux time (RT) with duplex ultrasound examination. Venous clinical improvement was evaluated using the revised Venous Clinical Severity Scale. RESULTS Of the 14 patients, 13 (93%) had successful formation of at least one monocuspid valve, with a mean number of 1.4 valves (range, 0-3 valves) per patient. There were no device-related serious adverse events during the index procedure. There were no deep venous thromboses reported at any time point, including 10 patients through the 1-year follow-up. In patients with at least one valve formed, site reported duplex ultrasound examination measured the average RT in the popliteal vein below valve formations, was 3.0 ± 1.0 seconds at baseline, 3.9 ± 3.1 seconds at 30 days, and 3.6 ± 2.1 seconds at 360 days. The revised Venous Clinical Severity Scale improved in all 13 successfully treated patients, decreasing from 15.0 ± 6.0 at baseline to 11.6 ± 5.5 at 30 days, 10.7 ± 5.3 at 210 days, and 9.4 ± 5.0 at 360 days (P = .0002; baseline to 360 days). Among the five patients with an ulcer who reached the 360-day follow-up visit, all (100%) healed at least one ulcer. Two patients (40%) healed all ulcers and three patients (60%) had a decrease in ulcers number but remained at C6 at 360 days. The five patients with a total of nine active ulcers at baseline had four active ulcers at 360 days. CONCLUSIONS The BlueLeaf System holds promise as a minimally invasive means to safely form fully autogenous deep venous valves. Reconstructed deep veins remained patent, without deep venous thrombosis and symptomatic improvement was consistently observed; however, a decrease in the RT was not. Incremental device design improvements have been undertaken to improve valve function. The results of these iterations await further clinical evaluation.
Collapse
Affiliation(s)
- Thodur Vasudevan
- Department of Vascular Surgery, The Alfred, Melbourne, Australia
| | - David A Robinson
- Department of Vascular Surgery, Royal Prince Alfred Hospital, Sydney, Australia
| | - Andrew A Hill
- Department of Vascular Surgery, Auckland City Hospital, Auckland, New Zealand
| | | | - Andrew Holden
- Department of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand
| | - Joel Gagnon
- Department of Vascular Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada
| | - Lindsay Machan
- Department of Interventional Radiology, Vancouver General Hospital, Vancouver, British Columbia, Canada
| | - Isuru Nammuni
- Department of Vascular Surgery, Royal Prince Alfred Hospital, Sydney, Australia
| | - Shannon D Thomas
- Department of Surgery, Prince of Wales Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
| | - Ramon L Varcoe
- Department of Surgery, Prince of Wales Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia.
| |
Collapse
|
10
|
Seridi N, Hamidouche M, Belmessabih N, El Kennani S, Gagnon J, Martinez G, Coutton C, Marchal T, Chebloune Y. Immortalization of primary sheep embryo kidney cells. In Vitro Cell Dev Biol Anim 2021; 57:76-85. [PMID: 33415664 DOI: 10.1007/s11626-020-00520-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2020] [Accepted: 10/13/2020] [Indexed: 10/22/2022]
Abstract
Sheep primary epithelial cells are short-lived in cell culture systems. For long-term in vitro studies, primary cells need to be immortalized. This study aims to establish and characterize T immortalized sheep embryo kidney cells (TISEKC). In this study, we used fetal lamb kidneys to derive primary cultures of epithelial cells. We subsequently immortalized these cells using the large T SV40 antigen to generate crude TISEKC and isolate TISEKC clones. Among numerous clones of immortalized cells, the selected TISEKC-5 maintained active division and cell growth over 20 passages but lacked expression of the oncogenic large T SV40 antigen. Morphologically, TISEKC-5 maintained their epithelial aspect similar to the parental primary epithelial cells. However, their growth properties showed quite different patterns. Crude TISEKC, as well as the clones of TISEKC proliferated highly in culture compared to the parental primary cells. In the early passages, immortalized cells showed heterogeneous polyploidy but in the late passages the karyotype of immortalized cells became progressively stable, identical to that of the primary cells, because the TISEKC-5 cell line has lost the large SV40 T antigen expression, this cell line is a valuable tool for veterinary sciences and biotechnological productions.
Collapse
Affiliation(s)
- N Seridi
- Laboratory of Molecular and Cellular Biology, Unit of Genetics, Faculty of Biological Sciences, University of Sciences and Technology "Houari Boumediene", Algiers, Algeria
| | - M Hamidouche
- Laboratory of Production and Development of Viral Veterinary Vaccines, Pasteur Institute of Algeria, Algiers, Algeria
| | - N Belmessabih
- Laboratory of Production and Development of Viral Veterinary Vaccines, Pasteur Institute of Algeria, Algiers, Algeria
| | - S El Kennani
- INRAE/UGA USC 1450, Pathogenesis and Lentivirus Vaccination Laboratory, PAVAL Lab, Université Grenoble Alpes, 38041, Grenoble Cedex 9, France
| | - J Gagnon
- INRAE/UGA USC 1450, Pathogenesis and Lentivirus Vaccination Laboratory, PAVAL Lab, Université Grenoble Alpes, 38041, Grenoble Cedex 9, France
| | - G Martinez
- CHU Grenoble Alpes, UM de Génétique Chromosomique, Grenoble, France.,INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Université Grenoble Alpes, 38000, Grenoble, France
| | - C Coutton
- CHU Grenoble Alpes, UM de Génétique Chromosomique, Grenoble, France.,INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Université Grenoble Alpes, 38000, Grenoble, France
| | - T Marchal
- VetAgro Sup, UPSP ICE 2011.03.101, Laboratoire d'Histopathologie, Université de Lyon, Marcy-l'Etoile, France
| | - Y Chebloune
- INRAE/UGA USC 1450, Pathogenesis and Lentivirus Vaccination Laboratory, PAVAL Lab, Université Grenoble Alpes, 38041, Grenoble Cedex 9, France.
| |
Collapse
|
11
|
Mordhorst A, Yang G, Zhang B, Suri S, Kizhakkedathu J, Gagnon J, Chen J. Evaluation of Hydrophilic Polymer Embolization From Endovascular Sheath Devices in an In Vitro Perfusion System. J Vasc Surg 2020. [DOI: 10.1016/j.jvs.2020.08.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Gasse A, Kim WS, Gagnon J. Association between depression and hostile attribution bias in hostile and non-hostile individuals: An ERP study. J Affect Disord 2020; 276:1077-1083. [PMID: 32771859 DOI: 10.1016/j.jad.2020.06.025] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Revised: 05/31/2020] [Accepted: 06/23/2020] [Indexed: 11/24/2022]
Abstract
BACKGROUND Hostility and aggression have been found to be highly prevalent among depressed patients and are associated with higher comorbidity and illness severity levels. Although negative interpretation biases are a fundamental element of cognitive models of depression, few studies have examined the specific biases in information processing, mainly the hostile attribution bias, found in hostile individuals who present depressive symptoms. METHOD Using pre-collected data from a sample of 72 (male=41,6%, female=58,3%) undergraduate and community-based hostile (n = 26) and non-hostile (n = 46) adult participants, the authors aimed to examine the association between depression and the hostile attribution bias by determining whether depression level scores were uniquely related to electrophysiological measures of the hostile attribution bias. RESULTS The hostile group showed higher measured levels of depression and reactive aggression compared to the non-hostile group. Also, depression scores were significant predictors of the N400 effect in the non-hostile task condition, while reactive aggression was not, whereas in the hostile condition, the overall model was significant, with depression and reactive aggression levels both showing strong trends towards significance. LIMITATIONS A small sample size limited the scope of our conclusions. Also, sample selection prevented us from examining specific group differences regarding the hostile attribution bias in depressed and non-depressed groups. CONCLUSION Clinical and research implications include the necessity to apply cognitive restructuring techniques to counter biased interpretation processes in settings where depression and aggression intersect, and the need to consider alternatives to self-evaluative methodologies.
Collapse
Affiliation(s)
- A Gasse
- Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal, Canada; Laboratoire d'électrophysiologie en neuroscience sociale (LENS), University of Montreal, Canada; School of Criminology, University of Montreal, Canada.
| | - W S Kim
- Department of Psychology, University of Montreal, Canada; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal, Canada; Laboratoire d'électrophysiologie en neuroscience sociale (LENS), University of Montreal, Canada
| | - J Gagnon
- Department of Psychology, University of Montreal, Canada; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal, Canada; Laboratoire d'électrophysiologie en neuroscience sociale (LENS), University of Montreal, Canada
| |
Collapse
|
13
|
Grégoire S, Gagnon J, Lachance L, Shankland R, Dionne F, Kotsou I, Monestès JL, Rolffs JL, Rogge RD. Validation of the english and french versions of the multidimensional psychological flexibility inventory short form (MPFI-24). Journal of Contextual Behavioral Science 2020. [DOI: 10.1016/j.jcbs.2020.06.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Breton M, Ann Smithman M, Lamoureux‐Lamarche C, Dumas Pilon M, Keely E, Farrell G, Singer A, Woods P, Bibeau C, Nabelsi V, Gaboury I, Gagnon M, Steele Gray C, Shaw J, Hudon C, Aubrey‐Bassler K, Bush P, Côté‐Boileau É, Gagnon J, Visca R, Liddy C. DISSEMINATION, IMPLEMENTATION, AND IMPACT. Health Serv Res 2020. [DOI: 10.1111/1475-6773.13409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- M. Breton
- University of Sherbrooke Longueuil QC Canada
| | | | | | - M. Dumas Pilon
- Collège québécois des médecins de famille Laval QC Canada
| | - E. Keely
- Department of Medicine University of Ottawa Ottawa ON Canada
| | | | - A. Singer
- University of Manitoba Winnipeg MB Canada
| | | | | | - V. Nabelsi
- Université du Québec en Outaouais Gatineau QC Canada
| | - I. Gaboury
- University of Sherbrooke Longueuil QC Canada
| | | | | | - J. Shaw
- Women's College Hospital Toronto ON Canada
| | - C. Hudon
- University of Sherbrooke Sherbrooke QC Canada
| | | | - P. Bush
- McGill University Montréal QC Canada
| | | | - J. Gagnon
- McGill University Montréal QC Canada
| | - R. Visca
- McGill University Montréal QC Canada
| | - C. Liddy
- Family Medicine C.T. Lamont Primary Health Care Research Centre Bruyère Research Institute Ottawa ON Canada
| |
Collapse
|
15
|
Campbell O, MacDonald VS, Dickinson RM, Gagnon J. Evaluation of the effect of vincristine on platelet count in dogs with lymphoma. J Small Anim Pract 2019; 60:734-738. [PMID: 31737905 DOI: 10.1111/jsap.13080] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2018] [Revised: 08/23/2019] [Accepted: 08/30/2019] [Indexed: 12/28/2022]
Abstract
OBJECTIVES To determine the effect of vincristine administration on the platelet count, platelet morphology and incidence of thrombocytopenia in dogs diagnosed with lymphoma. MATERIAL AND METHODS Medical records of 59 dogs with lymphoma receiving vincristine sulphate were reviewed retrospectively. RESULTS Following vincristine administration the platelet count was higher and the number of thrombocytopenic patients was lower. No difference was found in the number of dogs with enlarged and elliptical platelets following vincristine treatment. CLINICAL SIGNIFICANCE Vincristine administration increases platelet counts in dogs with lymphoma. It is not contra-indicated to administer vincristine to dogs with lymphoma that are thrombocytopenic.
Collapse
Affiliation(s)
- O Campbell
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5B4, Canada
| | - V S MacDonald
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5B4, Canada
| | - R M Dickinson
- Department of Veterinary Pathology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5B4, Canada
| | - J Gagnon
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5B4, Canada
| |
Collapse
|
16
|
Cieri UR, Bertrand R, Choi KK, Gagnon J, Krol P, Latzo P, Lau D, Melendez J, Pyramides G, Sen S, Steible D, Weigand J. Determination of Atropine (Hyoscyamine) Sulfate in Commercial Products by Liquid Chromatography with UV Absorbance and Fluorescence Detection: Multilaboratory Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/86.6.1128] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
A liquid chromatographic (LC) method with 2 detection systems for determining atropine (hyoscyamine) sulfate in commercial products was tested in a multilaboratory study. Depending on the type of product, sample solutions are prepared in methanol or methanol–water (1 + 1). The standard solution contains about 1.0 mg atropine sul-fate/100 mL and is prepared in the same solvent used in sample preparation. LC separations are performed on a 7.5 cm Novapak silica column. The mobile phase is prepared by mixing 970 mL methanol with 30 mL of a 1% aqueous solution of 1-pentanesulfonic acid, sodium salt. Detection is by 2 systems, UV absorbance detection at 220 nm and fluorescence detection with excitation at 255 nm and emission at 285 nm. The injection volume is 100 or 200 μL. The following materials were used for the study: 2 separate samples of tablets labeled to contain 0.4 mg atropine sulfate, 2 separate samples of extended-release tablets labeled to contain 0.375 mg hyoscyamine sulfate, one sample of atropine sulfate injection labeled to contain 2 mg/mL, and one sample of 1% (v/v) atropine sul-fate ophthalmic. Eight participants analyzed 2 separate portions of the 6 samples by both detection systems. A ninth participant analyzed the samples in duplicate but only by UV absorbance detection because of the unavailability of a fluorescence detector. The relative standard deviation (RSD) between laboratories ranged from 1.4 to 3.3% for samples of tablets and injections but higher for ophthalmic solutions (5.1–5.2%). A linearity study was conducted in the originating laboratory before the multilaboratory study with 5 solutions ranging in concentration from 0.80 to 1.20 mg atropine sul-fate in 100 mL. Average recoveries were 100.0% by UV absorbance detection and 99.9% by fluorescence detection; the RSDs were 1.1 and 1.2%, respectively.
Collapse
Affiliation(s)
- Ugo R Cieri
- U.S. Food and Drug Administration, 2nd and Chestnut Sts, Philadelphia, PA 19106
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Choi SHJ, Yang GK, Gagnon J. Dysphagia aortica secondary to thoracoabdominal aortic aneurysm resolved after endograft placement. J Vasc Surg Cases Innov Tech 2019; 5:501-505. [PMID: 31763508 PMCID: PMC6859279 DOI: 10.1016/j.jvscit.2019.08.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/12/2019] [Accepted: 08/16/2019] [Indexed: 11/27/2022]
Abstract
Dysphagia aortica is a rare entity defined as difficulty in swallowing due to external compression by the aorta. Aneurysmal dysphagia aortica successfully treated with thoracic endovascular aortic repair (TEVAR) is exceedingly rare. We report the case of a 74-year-old woman with known thoracoabdominal aneurysm who presented with acute shortness of breath and 3-month history of dysphagia. Computed tomography angiography revealed aneurysmal growth and massive esophageal dilation. She underwent TEVAR and visceral debranching, which led to complete symptom resolution correlated with sac regression. We also present a comprehensive review of the literature with a focus on cases of aneurysmal dysphagia aortica treated with TEVAR.
Collapse
Affiliation(s)
- Sally H J Choi
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Gary K Yang
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
18
|
Yang GK, Mordhorst A, Maguire J, Janusz M, Gagnon J. Hydrophilic polymer embolization after thoracic endovascular aortic repair. J Vasc Surg Cases Innov Tech 2019; 5:423-426. [PMID: 31660464 PMCID: PMC6806646 DOI: 10.1016/j.jvscit.2019.05.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/05/2019] [Accepted: 05/10/2019] [Indexed: 12/02/2022]
Abstract
Hydrophilic polymer embolization is a rare complication after endovascular procedures that is currently underappreciated. Present understanding on this phenomenon relies on sparse case reports with histologic evidence of foreign polymers in end-organ tissue. Here, we report two deaths associated with hydrophilic polymer embolization after complex thoracic endovascular aortic repair.
Collapse
Affiliation(s)
- Gary K. Yang
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Alexa Mordhorst
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - John Maguire
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Michael Janusz
- Division of Cardiac Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
- Correspondence: Joel Gagnon, MD, Division of Vascular Surgery, Department of Surgery, University of British Columbia, Rm 11115, 2775 Laurel St, Vancouver, BC, Canada V5Z 1M9
| |
Collapse
|
19
|
Campbell O, Gagnon J, Rubin JE. Antibacterial activity of chemotherapeutic drugs against Escherichia coli and Staphylococcus pseudintermedius. Lett Appl Microbiol 2019; 69:353-357. [PMID: 31508840 DOI: 10.1111/lam.13213] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2019] [Revised: 09/03/2019] [Accepted: 09/04/2019] [Indexed: 11/30/2022]
Abstract
The ability of chemotherapeutic agents to affect the growth of common bacterial pathogens and the relationship between the effects of chemotherapeutics and antimicrobials is largely unknown. The purpose of this study was to describe the susceptibility of canine bacterial isolates to chemotherapeutic agents and to compare these results to their antimicrobial susceptibility. The effects of bleomycin, doxorubicin, cytarabine, cyclophosphamide, methotrexate, 5-fluorouracil and gemcitabine on the growth of 33 Staphylococcus pseudintermedius isolates and 32 Escherichia coli isolates from dogs was determined by agar dilution. In addition to MICs, the lowest drug concentration associated with a decreased colony size was recorded. Results were compared to the MICs of a panel of antimicrobial agents. Bleomycin consistently inhibited bacterial growth of S. pseudintermedius and E. coli. Doxorubicin inhibited S. pseudintermedius but not E. coli while the opposite was seen for gemcitabine. Reduction in colony size on exposure to 5-fluorouracil for both organisms, and methotrexate for S. pseudintermedius was seen. No observable effect of cyclophosphamide or cytarabine was observed. Associations between elevated MICs to chemotherapeutic drugs and antimicrobial resistance were not found. These results indicate that chemotherapeutic agents affect the growth of bacteria, but do not support a role in the selection of antimicrobial resistance. SIGNIFICANCE AND IMPACT OF THE STUDY: This study shows that chemotherapy drugs commonly used in veterinary oncology have an effect of the growth of canine isolates of Escherichia coli and Staphylococcus pseudintermedius. No associations between susceptibility to chemotherapeutic drugs and antibiotics were found, which does not support selection of antimicrobial resistance by chemotherapy drugs.
Collapse
Affiliation(s)
- O Campbell
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - J Gagnon
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - J E Rubin
- Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| |
Collapse
|
20
|
Choi SH, Yang GK, Baxter K, Gagnon J. Evaluation of Aortic Zone 2 Landing Accuracy During Thoracic Endovascular Aortic Repair Following Carotid-Subclavian Revascularization. J Vasc Surg 2019. [DOI: 10.1016/j.jvs.2019.07.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
21
|
Yang GK, Chen J, Machan L, Gagnon J. Endovenous Deep Vein Valve Creation for the Treatment of Chronic Venous Insufficiency. J Vasc Surg 2019. [DOI: 10.1016/j.jvs.2019.07.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
22
|
Fung A, Mihaila L, Gagnon J, Chen J. Comparison of Endovenous Interventions Versus Stripping and Ligation for Varicose Veins Arising From the Popliteal Fossa. J Vasc Surg 2019. [DOI: 10.1016/j.jvs.2019.07.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
23
|
Yang GK, Misskey J, Arsenault K, Gagnon J, Janusz M, Faulds J. Outcomes of a Spinal Drain and Intraoperative Neurophysiologic Monitoring Protocol in Thoracic Endovascular Aortic Repair. Ann Vasc Surg 2019; 61:124-133. [PMID: 31344465 DOI: 10.1016/j.avsg.2019.04.022] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2018] [Revised: 04/09/2019] [Accepted: 04/10/2019] [Indexed: 01/16/2023]
Abstract
BACKGROUND Adjuncts for early detection and treatment of spinal cord ischemia (SCI) in thoracic aortic surgery are supported by robust clinical experience in open repair. The utility of cerebrospinal fluid (CSF) drainage and neurophysiologic monitoring (NPM) in thoracic endovascular aortic repair (TEVAR) is less clear. The purpose of this investigation is to determine the influence of a selective institutional spinal cord protection protocol using prophylactic NPM and CSF on outcomes for standard TEVAR. METHODS Patients undergoing standard TEVAR entered into a prospectively maintained database from a single institution from 2007 to 2016 were retrospectively reviewed. Preoperative characteristics, aneurysm extent, and etiology were reviewed. Utilization of CSF drains including volume of fluid removed, duration of drainage, and catheter-related complications were collected. NPM data were reviewed to determine the influence on intraoperative management. Exact logistic regression was used to identify independent predictors of SCI. RESULTS Of 223 patients undergoing TEVAR, 130 met inclusion criteria for the study. CSF drains were used in 71 patients (54.6%), and 56 of 130 (43%) had NPM. SCI occurred in 7 patients (5.4%), of whom 5 had partial or complete recovery. Median time to symptoms of SCI was delayed in all cases (median 52 hr, range 8-312), and none of the 4 of 7 patients with adjunct NPM demonstrated intraoperative changes. Intraoperative changes in NPM occurred in 26 (46%), and represented unilateral leg ischemia in all but 2 cases. In both patients, changes consistent with SCI were associated with intraoperative hypotension and resolved with blood pressure augmentation. Neither patient developed postoperative SCI. Median length of stay (22 vs. 9 days, P = 0.012), operative room time (262 vs. 209, P = 0.040), and perioperative mortality (28.6% vs. 4.1%, P = 0.046) were significantly higher for patients with SCI versus those without. Length of aortic coverage was found to be the sole independent predictor of SCI (odds ratio 8.2, P = 0.026). Complications related to CSF drainage occurred in 4 patients (5.6%) with major complications occurring in 2 patients (2.8%), including 1 with an intrathecal hematoma and permanent bilateral paraparesis. CONCLUSIONS Selective use of prophylactic CSF drainage in TEVAR was associated with moderate risk and questionable benefit. The use of neurophysiological monitoring allowed for early detection and treatment of spinal ischemia, but its utility is limited by logistical factors and to the minority of patients with intraoperative spinal ischemic events.
Collapse
Affiliation(s)
- Gary K Yang
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Jonathan Misskey
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada.
| | - Kyle Arsenault
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Michael Janusz
- Division of Cardiac Surgery, University of British Columbia, Vancouver, BC, Canada
| | - Jason Faulds
- Division of Vascular Surgery, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
24
|
Gagnon J, Dionne F, Raymond G, Grégoire S. Pilot study of a Web-based acceptance and commitment therapy intervention for university students to reduce academic procrastination. J Am Coll Health 2019; 67:374-382. [PMID: 29979942 DOI: 10.1080/07448481.2018.1484361] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/09/2017] [Revised: 04/26/2018] [Accepted: 05/29/2018] [Indexed: 06/08/2023]
Abstract
Objective: This pilot study pursued two aims. The first was to investigate the feasibility and acceptability of a Web-based acceptance and commitment therapy (ACT) intervention to reduce academic procrastination among university students. The second aim was to test the effectiveness of the intervention on procrastination and committed actions. Participants: The sample was comprised of Canadian university students (n = 36) that participated in the intervention between September 2016 and April 2017. Methods: The study relied on a prepost research design. Results: The intervention appears feasible, acceptable, and valuable to students. A significant reduction in procrastination and a significant improvement in committed actions were found between pre and postintervention. The effect sizes for these results were medium. Conclusions: Results provide preliminary support for the feasibility and effectiveness of a Web-based ACT intervention for academic procrastination. Results also highlight some aspects that need to be improved for further development.
Collapse
Affiliation(s)
- Joel Gagnon
- a Université du Québec à Trois-Rivières , Trois-Rivières, Québec , Canada
| | - Frédérick Dionne
- a Université du Québec à Trois-Rivières , Trois-Rivières, Québec , Canada
| | - Guillaume Raymond
- a Université du Québec à Trois-Rivières , Trois-Rivières, Québec , Canada
| | - Simon Grégoire
- b Université du Québec à Montréal , Montréal, Québec , Canada
| |
Collapse
|
25
|
Peixoto EM, Gagnon J, Jeffcoat TR. Inventário Reno de Autoperspectiva RISP: Adaptação Transcultural e Evidência de Validade. Psico-USF 2019. [DOI: 10.1590/1413-82712019240202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Resumo Esta pesquisa teve como objetivos a adaptação transcultural e avaliação das propriedades psicométricas da versão brasileira do Reno Inventory of Self-Perspective - RISP, instrumento que avalia a habilidade de tomada de perspectiva, compreensão de si mesmo enquanto construção contextual, por meio dos fatores enredado, centrado e transcendente. A amostra foi composta por 344 universitários (idade 21,1 ± 4,8; 64,2% mulheres). A estrutura interna foi estimada por meio do Exploratory Structural Equation Modeling (ESEM). Também se avaliou a invariância do modelo fatorial entre participantes do sexo masculino e feminino, indicadores de precisão e associação com variáveis externas: satisfação com a vida, fusão cognitiva, ansiedade, estresse e depressão. Os resultados revelaram a estrutura composta por três fatores, conforme hipótese teórica, com indicadores desejáveis de precisão. Foi demonstrado equivalência do modelo de medida ao avaliar participantes dos diferentes sexos, e associações correspondentes as perspectivas teóricas com as variáveis externas estudadas. Os resultados sugerem adequação da versão brasileira RISP.
Collapse
Affiliation(s)
| | - Joel Gagnon
- Universté du Quebéc à Trois Rivieres, Canadá
| | | |
Collapse
|
26
|
Yang GK, Mordhorst A, Gagnon J. Ultrasound-Guided Cyanoacrylate Injection for the Treatment of Incompetent Perforator Veins. J Vasc Surg 2018. [DOI: 10.1016/j.jvs.2018.06.159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Yang GK, Parapini M, Gagnon J, Chen JC. Comparison of cyanoacrylate embolization and radiofrequency ablation for the treatment of varicose veins. Phlebology 2018; 34:278-283. [PMID: 30114987 DOI: 10.1177/0268355518794105] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVE To review clinical outcomes of varicose vein patients treated with cyanoacrylate embolization and radiofrequency ablation at our institution. METHODS A retrospective review of patients who underwent cyanoacrylate embolization and radiofrequency ablation during a three-year period. Patient records were reviewed to assess demographics, location and severity of disease, treatment details and outcome at short- and mid-term follow-ups. Outcome parameters included treatment success and complications. RESULTS Between January 2014 and December 2016, 335 patients with 476 veins were treated with either cyanoacrylate embolization (n = 148) or radiofrequency ablation (n = 328) at the Vancouver General Hospital Vascular Surgery Vein Clinic. The average age of patients were 57 ± 1 years with the majority being female (78%) and an average BMI of 24.8 ± 0.5. CEAP classes were 2 (49%), 3 (26%), 4a (22%) and >4b (3%). Of the veins treated with cyanoacrylate embolization, the vein types were as follows: 76% were great saphenous vein, 16% were small saphenous vein, 5% were anterior accessory great saphenous vein and 1.4% were perforator veins. The vein types for radiofrequency ablation were 88%, 9%, 3% and 0%, respectively. The average amount of cyanoacrylate embolization delivered for great saphenous vein treatment was 1.8 ± 0.1 ml with a treatment length of 43 ± 1 cm. Subgroup comparison was done for great saphenous vein segments. Treatment success was 100% in cyanoacrylate embolization and 99% in radiofrequency ablation. Superficial phlebitis was the most common complication noted at mid-term follow-up in 5% of cyanoacrylate embolization and 16% of radiofrequency ablation treatments (P < 0.05). One patient in each group had asymptomatic proximal thrombus extension treated with anticoagulation for 2-3 weeks. Three superficial infections from glue clumps were noted in the cyanoacrylate embolization group requiring excision and drainage. Five patients in the radiofrequency ablation group had persistent numbness and one wound complications at the access site. CONCLUSION Cyanoacrylate embolization offers equivalent success rates with lower mid-term complication rates as radiofrequency ablation.
Collapse
Affiliation(s)
- Gary K Yang
- Division of Vascular Surgery, University of British Columbia, Vancouver, Canada
| | - Marina Parapini
- Division of Vascular Surgery, University of British Columbia, Vancouver, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, University of British Columbia, Vancouver, Canada
| | - Jerry C Chen
- Division of Vascular Surgery, University of British Columbia, Vancouver, Canada
| |
Collapse
|
28
|
Latreille V, Gaubert M, Dubé J, Lina J, Gagnon J, Carrier J. 0272 Thinning of Medial Frontal and Anterior Cingulate Cortices Explain Age-related Changes in REM and NREM Sleep. Sleep 2018. [DOI: 10.1093/sleep/zsy061.271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- V Latreille
- Centre d’études avancées en médecine du sommeil, Hôpital du Sacré-Coeur de Montréal, Montreal, QC, CANADA
- Department of Psychology, University of Montreal, Montreal, QC, CANADA
| | - M Gaubert
- Centre d’études avancées en médecine du sommeil, Hôpital du Sacré-Coeur de Montréal, Montreal, QC, CANADA
- Department of Psychology, University of Quebec in Montreal, Montreal, QC, CANADA
| | - J Dubé
- Centre d’études avancées en médecine du sommeil, Hôpital du Sacré-Coeur de Montréal, Montreal, QC, CANADA
- Department of Psychology, University of Montreal, Montreal, QC, CANADA
| | - J Lina
- Centre d’études avancées en médecine du sommeil, Hôpital du Sacré-Coeur de Montréal, Montreal, QC, CANADA
- Department of Electrical Engineering, École de Technologie Supérieure, Montreal, QC, CANADA
| | - J Gagnon
- Centre d’études avancées en médecine du sommeil, Hôpital du Sacré-Coeur de Montréal, Montreal, QC, CANADA
- Department of Psychology, University of Quebec in Montreal, Montreal, QC, CANADA
| | - J Carrier
- Centre d’études avancées en médecine du sommeil, Hôpital du Sacré-Coeur de Montréal, Montreal, QC, CANADA
- Department of Psychology, University of Montreal, Montreal, QC, CANADA
| |
Collapse
|
29
|
Gagnon K, Baril A, Montplaisir J, Carrier J, Chami S, Gauthier S, Lafond C, Gagnon J, Gosselin N. 0593 Detection Of Mild Cognitive Impairment In Older Individuals With Obstructive Sleep Apnea. Sleep 2018. [DOI: 10.1093/sleep/zsy061.592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K Gagnon
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | - A Baril
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | - J Montplaisir
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | - J Carrier
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | - S Chami
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | | | - C Lafond
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | - J Gagnon
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| | - N Gosselin
- Center for Advanced Research in Sleep Medicine, Montréal, QC, CANADA
| |
Collapse
|
30
|
Misskey J, Faulds J, Sidhu R, Baxter K, Gagnon J, Hsiang Y. An age-based comparison of fistula location, patency, and maturation for elderly renal failure patients. J Vasc Surg 2017; 67:1491-1500. [PMID: 29224945 DOI: 10.1016/j.jvs.2017.08.080] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2016] [Accepted: 08/14/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVE Current Kidney Disease Outcomes Quality Initiative guidelines do not incorporate age in determining autogenous arteriovenous hemodialysis access placement, and the optimal initial configuration in elderly patients remains controversial. We compared patency, maturation, survival, and complications between several age cohorts (<65 years, 65-79 years, >80 years) to determine whether protocols should be modified to account for advanced age. METHODS All patients at two teaching hospitals undergoing a first autogenous arteriovenous access creation in either arm between 2007 and 2013 were retrospectively analyzed from a prospectively maintained database. Kaplan-Meier survival and Cox hazards models were used to compare access patency and risk factors for failure. RESULTS There were 941 autogenous arteriovenous accesses (median follow-up, 23 months; range, 0-89 months) eligible for inclusion; 152 (15.3%) accesses were created in those >80 years, 397 (42.2%) in those 65 to 79 years, and 392 (41.8%) in those <65 years. Primary patencies in patients >80 years, 65 to 79 years, and <65 years were 40% ± 4%, 38% ± 3%, and 51% ± 3% at 12 months and 12% ± 5%, 13% ± 3%, and 27% ± 3% at 36 months (P < .001). Primary assisted patencies were 72% ± 4%, 70% ± 2%, and 78% ± 2% at 12 months and 52% ± 5%, 52% ± 3%, and 67% ± 3% at 36 months (P < .001). Secondary patencies were 72% ± 4%, 71% ± 2%, and 79% ± 2% at 12 months and 54% ± 5%, 55% ± 3%, and 72% ± 3% at 36 months (P < .001). Radiocephalic patencies were lowest among older cohorts; in those >80 years, 65 to 79 years, and <65 years, they were 65% ± 7%, 67% ± 4%, and 77% ± 3% at 12 months and 41% ± 8%, 51% ± 5%, and 68% ± 4% at 36 months (P = .019). Secondary brachiocephalic access patencies in these cohorts were 78% ± 5%, 80% ± 3%, and 82% ± 3% at 12 months and 68% ± 7%, 66% ± 5%, and 77% ± 4% at 36 months (P = .206). Both the age groups 65 to 79 years and >80 years demonstrated superior brachiocephalic vs radiocephalic secondary patencies (P = .048 and P = .015, respectively); however, no differences between configuration and secondary patency were observed within the cohort <65 years. Radiocephalic access maturation failure at 12 and 24 months was 25% ± 3% and 29% ± 4% in those <65 years, 32% ± 3% and 39% ± 4% in those 65 to 79 years, and 40% ± 7% and 48% ± 8% in those >80 years (P = .006). Brachiocephalic access maturation failures were 17% ± 3% and 20% ± 3% at 12 and 24 months in those <65 years, 21% ± 3% and 25% ± 4% in those 65 to 79 years, and 18% ± 5% and 21% ± 5% in those >80 years (P = .740). On multivariate analysis, coronary disease, female sex, previous ipsilateral or bilateral catheters, radiocephalic configuration, and age >65 years were associated with secondary patency loss. CONCLUSIONS Patients aged 65 to 79 years and >80 years had inferior primary, primary assisted, and secondary patency and maturation compared with those <65 years. When stratified by configuration, radiocephalic accesses demonstrated lower patency and maturation compared with brachiocephalic accesses for patients aged 65 to 79 years and >80 years and were an independent predictor of secondary patency loss.
Collapse
Affiliation(s)
- Jonathan Misskey
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
| | - Jason Faulds
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Division of Vascular Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada
| | - Ravi Sidhu
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Division of Vascular Surgery, Saint Paul's Hospital, Vancouver, British Columbia, Canada
| | - Keith Baxter
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Division of Vascular Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada
| | - Joel Gagnon
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Division of Vascular Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada
| | - York Hsiang
- Division of Vascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Division of Vascular Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada
| |
Collapse
|
31
|
Arsenault KA, Tse LW, Gagnon J, Kelton D, Baxter K, Chen J, Johnson W, Kapila V. Venous Arterialization for Nonreconstructible Lower Extremity Arterial Disease: A Multicenter Case Series. J Vasc Surg 2017. [DOI: 10.1016/j.jvs.2017.07.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
32
|
Hamidizadeh R, Misskey J, Faulds J, Chen J, Gagnon J, Hsiang Y. Influence of Arterial and Venous Diameters on Autogenous Arteriovenous Access Patency. J Vasc Surg 2017. [DOI: 10.1016/j.jvs.2017.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
33
|
Yang GK, Parapini M, Gagnon J, Chen J. Comparison of Cyanoacrylate (VenaSeal) and Radiofrequency Ablation for Treatment of Varicose Veins in a Canadian Population. J Vasc Surg 2017. [DOI: 10.1016/j.jvs.2017.07.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
34
|
Gagnon J, Dionne F, Balbinotti M, Monestès JL. Dimensionality and validity of the Committed Action Questionnaire (CAQ-8) in a chronic pain and university student population. Journal of Contextual Behavioral Science 2017. [DOI: 10.1016/j.jcbs.2017.06.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
Vedel I, Arsenault-Lapierre G, Ladores M, Saad H, Gagnon J, D’Souza V, Kremer B. EFFECT OF A PRIMARY CARE VIRTUAL WARD ON THE READMISSION RATES OF OLDER PATIENTS POST DISCHARGE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- I. Vedel
- Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada,
- Department of Family Medicine, McGill University, Montreal, Quebec, Canada
| | | | - M. Ladores
- Herzl Family Practice Center, Jewish General Hospital, Montreal, Quebec, Canada,
| | - H. Saad
- Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada,
- Department of Family Medicine, McGill University, Montreal, Quebec, Canada
| | - J. Gagnon
- Department of Family Medicine, McGill University, Montreal, Quebec, Canada
| | - V. D’Souza
- Herzl Family Practice Center, Jewish General Hospital, Montreal, Quebec, Canada,
| | - B. Kremer
- Herzl Family Practice Center, Jewish General Hospital, Montreal, Quebec, Canada,
| |
Collapse
|
36
|
Hadjivassiliou A, Gagnon J, Janusz M, Klass D. Combined CT, Fluoroscopic and IVUS Guidance for Percutaneous Treatment of a Postsurgical Pseudoaneurysm Following Repair of Ascending Thoracic Aortic Aneurysm. Cardiovasc Intervent Radiol 2017; 40:1945-1949. [PMID: 28584942 DOI: 10.1007/s00270-017-1710-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Accepted: 05/23/2017] [Indexed: 11/29/2022]
Abstract
Thoracic aortic pseudoaneurysms are a recognized complication following aortic arch replacement. The established first line treatment is surgical repair; however, this may not be feasible in all patients. Percutaneous treatment of ascending thoracic pseudoaneurysms has been described as an alternative for nonsurgical candidates. Utilization of multimodality imaging can prove invaluable in minimizing the risk of potentially fatal intra-procedural complications. We present a case of successful embolization using computer tomography-guided direct percutaneous puncture of the pseudoaneurysm, with concomitant endovascular treatment under fluoroscopic and intravascular ultrasound guidance in a patient with challenging vascular anatomy.
Collapse
Affiliation(s)
- Anastasia Hadjivassiliou
- Department of Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada
| | - Joel Gagnon
- Department of Vascular Surgery, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada
| | - Michael Janusz
- Department of Cardiovascular Surgery, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada
| | - Darren Klass
- Department of Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada. .,Interventional Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
| |
Collapse
|
37
|
|
38
|
Bernier-Lalonger L, Bourgouin P, Escudier F, Postuma R, Génier Marchand D, De Roy J, Montplaisir J, Gagnon J. 0723 OLFACTION AND COLOR DISCRIMINATION DYSFUNCTIONS IN RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER: ASSOCIATION WITH MILD COGNITIVE IMPAIRMENT. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Gagnon K, Baril A, Montplaisir J, Carrier J, D’Aragon C, Gauthier S, Lafond C, Gagnon J, Gosselin N. 0283 SUBJECTIVE COGNITIVE COMPLAINT IN LATE MIDDLE-AGED AND OLDER INDIVIDUALS WITH OBSTRUCTIVE SLEEP APNEA. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.282] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Bourgouin P, Bernier-Lalonger L, Escudier F, B Postuma R, Génier Marchand D, De Roy J, Montplaisir J, Gagnon J. 0726 MOOD AND SLEEP QUALITY SYMPTOMS ARE NOT LINKED TO MILD COGNITIVE IMPAIRMENT IN RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.725] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
41
|
Brayet P, Lafrenière A, Petit D, Gagnon J, Gosselin N, Lina J, Carrier J, Montplaisir J. 0284 FUNCTIONAL CONNECTIVITY DURING REM SLEEP IN HEALTHY AGING. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Pelletier A, Adam B, Gagnon J, Postuma RB, Paquet J, Montplaisir J. 0727 TONIC AND PHASIC CHIN EMG DENSITY IN IDIOPATHIC REM SLEEP BEHAVIOR DISORDER. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. ACTA ACUST UNITED AC 2016; 23:e615-e625. [PMID: 28050152 DOI: 10.3747/co.23.2961] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
In recent years, risk stratification has sparked interest as an innovative approach to disease screening and prevention. The approach effectively personalizes individual risk, opening the way to screening and prevention interventions that are adapted to subpopulations. The international perspective project, which is developing risk stratification for breast cancer, aims to support the integration of its screening approach into clinical practice through comprehensive tool-building. Policies and guidelines for risk stratification-unlike those for population screening programs, which are currently well regulated-are still under development. Indeed, the development of guidelines for risk stratification reflects the translational aspects of perspective. Here, we describe the risk stratification process that was devised in the context of perspective, and we then explain the consensus-based method used to develop recommendations for breast cancer screening and prevention in a risk-stratification approach. Lastly, we discuss how the recommendations might affect current screening policies.
Collapse
Affiliation(s)
- J Gagnon
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - E Lévesque
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | | | - F Borduas
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard)
| | - J Chiquette
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard)
| | - C Diorio
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard)
| | - N Duchesne
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard)
| | - M Dumais
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - L Eloy
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire (chu) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard);; Joliette, QC: Centre hospitalier régional de Lanaudière (Eloy)
| | - W Foulkes
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - N Gervais
- Rivière-du-Loup, QC: Centre hospitalier du Grand-Portage (Gervais)
| | - L Lalonde
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - B L'Espérance
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - S Meterissian
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - L Provencher
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard)
| | - J Richard
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - C Savard
- St-Raymond, QC: Centre de santé et de services sociaux de Portneuf (Savard)
| | - I Trop
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - N Wong
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - B M Knoppers
- Montreal, QC: Centre of Genomics and Policy, Department of Human Genetics, McGill University (Gagnon, Lévesque, Knoppers); Quebec Breast Cancer Foundation [Dumais (observing member)]; Sir Mortimer B. Davis Jewish General Hospital and McGill University Health Centre (Foulkes); Breast Imaging Centre, Centre hospitalier de l'Université de Montréal (Lalonde, Trop); Hôpital du Sacré-Coeur de Montréal and Groupe d'Étude en Oncologie du Québec (L'Espérance); Royal Victoria Hospital and Cedars Breast Clinic of the McGill University Health Centre (Meterissian); Centre Intégré en traitement, recherche et enseignement en Cancer du Sein, Centre hospitalier de l'Université de Montréal (Richard); Sir Mortimer B. Davis Jewish General Hospital and McGill University (Wong)
| | - J Simard
- Quebec City, QC: Public Health Branch, Capitale-Nationale (Borduas); Centre hospitalier universitaire ( chu ) de Québec-Université Laval (Chiquette, Duchesne, Provencher); Centre de coordination des services régionaux, Capitale-Nationale (Chiquette); Quebec Breast Cancer Screening Program (Chiquette, Eloy); chu de Québec-Université Laval Research Center and Department of Social and Preventive Medicine, Université Laval (Diorio); Cancer Branch, Ministry of Health and Social Services (Eloy); Deschênes-Fabia Breast Diseases Center (Provencher); chu de Québec-Université Laval (Duchesne); Canada Research Chair in Oncogenetics, chu de Québec-Université Laval Research Centre, and Department of Molecular Medicine, Université Laval (Simard)
| |
Collapse
|
44
|
Arsenault KA, Chen JC, Gagnon J, Hsiang YN. Venous Stenting for Lower Extremity Venous Occlusive Disease: The Vancouver General Hospital Experience. J Vasc Surg 2016. [DOI: 10.1016/j.jvs.2016.08.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Carrier Emond F, Nolet K, Cyr G, Rouleau JL, Gagnon J. Sexual impulsivity and problematic sexual behaviors in adults: Towards innovative domain-specific behavioral measures. Sexologies 2016. [DOI: 10.1016/j.sexol.2015.12.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
46
|
Dionne F, Gagnon J, Balbinotti M, Peixoto EM, Martel ME, Gillanders D, Monestès JL. "Buying into thoughts”: Validation of a French translation of the Cognitive Fusion Questionnaire. ACTA ACUST UNITED AC 2016. [DOI: 10.1037/cbs0000053] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
47
|
Gagnon J, Dionne F, Pychyl TA. Committed action: An initial study on its association to procrastination in academic settings. Journal of Contextual Behavioral Science 2016. [DOI: 10.1016/j.jcbs.2016.04.002] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Gagnon J, Clift MJD, Vanhecke D, Widnersson IE, Abram SL, Petri-Fink A, Caruso RA, Rothen-Rutishauser B, Fromm KM. Synthesis, characterization, antibacterial activity and cytotoxicity of hollow TiO2-coated CeO2nanocontainers encapsulating silver nanoparticles for controlled silver release. J Mater Chem B 2016; 4:1166-1174. [DOI: 10.1039/c5tb01917f] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This novel type of nanocontainers offers the concept of potentially controlling silver delivery for the prevention of implant-associated infections.
Collapse
Affiliation(s)
- J. Gagnon
- Department of Chemistry and Fribourg Center for Nanomaterials
- University of Fribourg
- 1700 Fribourg
- Switzerland
- PFPC
| | - M. J. D. Clift
- Adolphe Merkle Institute
- University of Fribourg
- 1700 Fribourg
- Switzerland
| | - D. Vanhecke
- Adolphe Merkle Institute
- University of Fribourg
- 1700 Fribourg
- Switzerland
| | - I. E. Widnersson
- PFPC
- School of Chemistry
- The University of Melbourne
- Melbourne, Victoria 3010
- Australia
| | - S.-L. Abram
- Department of Chemistry and Fribourg Center for Nanomaterials
- University of Fribourg
- 1700 Fribourg
- Switzerland
| | - A. Petri-Fink
- Adolphe Merkle Institute
- University of Fribourg
- 1700 Fribourg
- Switzerland
| | - R. A. Caruso
- PFPC
- School of Chemistry
- The University of Melbourne
- Melbourne, Victoria 3010
- Australia
| | | | - K. M. Fromm
- Department of Chemistry and Fribourg Center for Nanomaterials
- University of Fribourg
- 1700 Fribourg
- Switzerland
| |
Collapse
|
49
|
Liu D, Peterson E, Dooner J, Baerlocher M, Zypchen L, Gagnon J, Delorme M, Sing CK, Wong J, Guzman R, Greenfield G, Moodley O, Yenson P. Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline. CMAJ 2015; 187:1288-1296. [PMID: 26416989 PMCID: PMC4646749 DOI: 10.1503/cmaj.141614] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Affiliation(s)
- David Liu
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask.
| | - Erica Peterson
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - James Dooner
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Mark Baerlocher
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Leslie Zypchen
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Joel Gagnon
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Michael Delorme
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Chad Kim Sing
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Jason Wong
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Randolph Guzman
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Gavin Greenfield
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Otto Moodley
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| | - Paul Yenson
- Department of Radiology (Liu), Division of Hematology, Department of Medicine (Peterson, Zypchen, Yenson), Department of Vascular Surgery (Gagnon), Vancouver General Hospital, Vancouver, BC; Vascular Surgery Victoria (Dooner), Victoria General Hospital, Victoria, BC; Department of Interventional Radiology (Baerlocher), University of Toronto, Toronto, Ont.; Department of Hematology (Delorme), Kelowna General Hospital, Kelowna, BC; Departments of Emergency Medicine (Kim Sing) and Radiology (Wong), Foothills Medical Centre, Calgary, Alta.; Department of Vascular Surgery (Guzman), St. Boniface Hospital, Winnipeg, Man.; Department of Emergency Medicine (Greenfield), University of Calgary, Calgary, Alta.; Department of Hematology (Moodley), Royal University Hospital, Saskatoon, Sask
| |
Collapse
|
50
|
Misskey J, Johnson S, Baxter K, Gagnon J. Using a Chimney to Make a Sandwich: Salvage of a Multibranched Thoracoabdominal Aortic Endograft with a Type IIIb Endoleak. Ann Vasc Surg 2015; 29:1660.e5-10. [DOI: 10.1016/j.avsg.2015.06.081] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2014] [Accepted: 06/28/2015] [Indexed: 12/20/2022]
|